A large observational study found no increased risk for cardiovascular events associated with azithromycin (Zithromax, Pfizer) in a general population of young and middle-age adults. In a paper published in the New England Journal of Medicine, Danish investigators report the results of a large national observational study comparing people who took azithromycin with matched controls…
Danish Study Finds No Increased CV Risk With Azithromycin In General Population
May 1, 2013 by Leave a Comment
You Know Nothing, Dr. Snow: Why Medicine Can’t Be More Like Facebook
May 18, 2012 by 3 Comments
Medicine can never be like Facebook, despite what Matt Herper argues over at Forbes. Perhaps he was just trolling for hits on a day when everyone is thinking about the Facebook IPO, but Herper proposed, with apparently seriousness, that medicine needs to model itself on the tech world in order to match the kind of…
Recent Comments